Gene: ZMYND19
Official Full Name: zinc finger MYND-type containing 19provided by HGNC
Gene Summary: ZMYND19 is a MYND zinc finger domain-containing protein that binds to the C terminus of melanin-concentrating hormone receptor-1 (MCHR1; MIM 601751) (Bachner et al., 2002 [PubMed 12208518]), and to the N termini of alpha-tubulin (TUBA1; MIM 191110), and beta-tubulin (TUBB; MIM 191130) (Francke et al., 2005 [PubMed 16039987]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30534 | ZMYND19 Knockout cell line (HeLa) | Human | ZMYND19 | 1:3~1:6 | Negative | Online Inquiry |
KO30535 | ZMYND19 Knockout cell line (HCT 116) | Human | ZMYND19 | 1:2~1:4 | Negative | Online Inquiry |
KO30536 | ZMYND19 Knockout cell line (HEK293) | Human | ZMYND19 | 1:3~1:6 | Negative | Online Inquiry |
KO30537 | ZMYND19 Knockout cell line (A549) | Human | ZMYND19 | 1:3~1:4 | Negative | Online Inquiry |
ZMYND19 Gene Knockout Cell Lines are specifically engineered cellular systems designed to study the biological functions of the ZMYND19 gene through targeted gene deletion. This innovative product allows researchers to investigate the role of ZMYND19 in various cellular processes, including transcription regulation, cell differentiation, and tumorigenesis. Utilizing the CRISPR/Cas9 gene-editing technology, these cell lines are constructed to facilitate precise knockout of the ZMYND19 gene, thus enabling a thorough examination of its contributions to cellular pathways and disease mechanisms.
The key functions of ZMYND19 revolve around its role as a chromatin reader, affecting gene expression by associating with epigenetic modifications. By employing these knockout cell lines, researchers can elucidate how the absence of ZMYND19 alters cellular behavior, potentially leading to insights into cancer biology and other significant health issues. In clinical settings, understanding the ZMYND19 gene’s function may facilitate the identification of novel therapeutic targets or biomarkers, enhancing personalized medicine strategies.
One of the unique advantages of ZMYND19 Gene Knockout Cell Lines is their specificity and reproducibility. Unlike traditional gene-editing methods, which may lead to off-target effects or incomplete knockouts, the CRISPR/Cas9 technique provides a high degree of accuracy and efficiency. This specificity not only saves time but also reduces the resources needed for downstream applications, making it an economical choice for research teams.
Valuable to researchers in oncology, genetics, and cell biology, these knockout cell lines provide a powerful tool for dissecting gene functions and interactions within various biological contexts. By incorporating ZMYND19 Gene Knockout Cell Lines into research protocols, scientists can innovate and advance their understanding of complex biological systems, ultimately driving scientific discovery.
Our company, with extensive experience in developing high-quality biological products, is committed to empowering researchers and clinicians with cutting-edge tools that facilitate groundbreaking scientific exploration.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.